Abstract
Human heart valves have been used in transplant surgery for nearly sixty years and banking of valves has been performed for the majority of this time. Cardiac valves have been disinfected using chemical agents, radiation and in present times by antibiotics and stored freeze dried or in solution at +4 ℃, solid carbon dioxide and nowadays in the vapour phase of liquid nitrogen refrigerators. Heart valve banks have a list of criteria that valves must meet with relation to age of donor, atheroma, fenestrations and absence of virological markers. Cardiac valves are normally tested for microbiological contamination at least twice during their processing. The main research topics of interest in the development of heart valve banking today concern ensuring that the mechanical properties of the valves are maintained, whether it is advantageous to decellularize the valves as this lowers immune response and if vitrification could be a storage method for the future as this could alleviate the need for low temperature during transportation. Consideration also needs to be made as to whether matching of valves improves results. In the early days of heart valve banking, most hospitals processed their own valves but in the twenty-first century most banking is performed by centralized units which may be companies, national blood services or banks that are a collaborative between hospitals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ross DN (1962) Homograft replacement of the aortic valve. Lancet 2(7254):487
Starr A, Herr RH, Wood JA (1965) The present status of valve replacement. Acta Chirurgia Scand 374:1–87
Bjork VO, Holmgren A, Olin C, Ovenfors CO (1971) Clinical and haemodynamic results of aortic valve replacement with Bjork-Shiley tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg 5:177–191
Carpentier A (1971) The concept of biorposthesis. Thoraxchirurgie Vaskulare Chirurgie 19:379–383
Mary DA, Pakrashi BC, Catchpole DW, Ionescu MI (1975) Tissue valves in the mitral position: 5 years experience. Br Heart J 37:1123–1132
Ionescu MI, Ross DN, Deac R et al (1970) Autologous fascia lata for heart valve replacement. Thorax 25:46–56
Zerbini EJ (1975) Results of replacement of cardiac valves by homologous dura mater valves. Chest 67:706–710
Deac RF, Simionescu D, Deac D (1995) New evolution in mitral physiology and surgery: mitral stentless pericardial valve. Ann Thorac Surg 60:5433–5438
Acar C, Tolan M, Berrebi A et al (1996) Homograft replacement of the mitral valve selection, technique of implantation and results in 43 patients. J Thorac Cardiovasc Surg 111:367–380
Agvirregoicoa V, Kearney JN, Davies GA, Gowland G (1989) Effects of antifungals on viability of heart valve cusp derived fibroblasts. Cardiovasc Res 23:1058–1061
Brockbank KG, Dawson PE (1993) Cytotoxicity of amhotericin B for fibroblasts in human heart valve leaflets. Cryobiology 30:19–24
Birtsas V, Armitage WJ (2005) Heart valve cryopreservation: Protocol for addition of dimethyl sulphoxide and amelioration of putative amphotericin B toxicity. Cryobiology 50:139–143
Waterworth PM, Lockey E, Berry EM, Pearce HM (1974) A critical investigation into the antibiotic sterilization of heart valve homografts. Thorax 29:432–436
Wain WH, Pearce HM, Riddell RW, Ross DN (1977) A re-evaluation of antibiotic sterilization of heart valve allografts. Thorax 32:740–742
Yacoub M, Kittle CF (1970) Sterilization of valve homografts by antibiotic solutions. Circulation 41(Suppl II):29–32
Leeming JP, Lovering AM, Hunt CJ (2005) Residual antibiotics in heart valve tissue samples following antibiotic disinfection. J Hosp Infec 60:231–234
Anyanwu CH, Nassau E, Yacoub M (1976) Miliary tuberculosis following homograft valve replacement. Thorax 31:101–106
Warwick RM, Magee JG, Leeming JP et al (2008) Mycobacteria and allograft heart valve banking: an international survey. J Hosp Infect 68:255–261
Mirabet V, Carda C, Solves P et al (2008) Long Term storage in liquid nitrogen does not affect cell viability in cardiac valve allografts. Cryobiol 57:113–121
Hunt CJ, Song YC, Bateson EAJ, Pegg DE (1994) Fractures in Ccyopreserved arteries. Cryobiol 31(5):506–515
Wassenaar C, Wijsmuller EG, Van Herwerden LA et al (1995) Cracks in cryopreserved aortic allografts and rapid thawing. Ann Thorac Surg 60:S165–S167
Wright JEC, Ng YL (1974) Elasticity of human aortic valve cusps. Cardiovasc Res 8:384–390
Wassenaar C, Bax WA, Van Suylen RJ et al (1997) Effects of cryopreservation on contractile properties of porcine isolated aortic valve leaflets and aortic wall. J Thorac Cardiovasc Surg 113:165–172
Vesely I, Gonzalez Lavin L, Graf D, Bouchner D (1990) Mechanical testing of cryopreserved aortic allografts, comparison with xenografts and fresh tissue. J Thorac Cardiovasc Surg 99:119–123
Gall K, Smith SE, Willmette CA, O’Brien M (1998) Allograft heart valve viability and valve processing variables. Ann Thorac Surg 65:1032–1038
Yacoub M, Rasmi NR, Sundt TM et al (1995) Fourteen year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 110:186–194
Elkins RC, Lane NM, Cappa SB et al (2001) Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Sem Thorac Cardiovasc Surg 13:82–86
Da Costa FDA, Costa ACBA, Prestes $R et al (2010) The early and mid term function of decellularised aortic valve allografts. Ann Thorac Surg 90:1854–1861
Cebotari S, Tudorache I, Ciubotaru A et al (2011) Use of fresh decellularised allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circ 124:S115–S123
Neumann A, Sarikouch S, Breymann T et al (2014) Early systemic cellular immune response in children and young adults receiving decellularised fresh allografts for pulmonary valve replacement. Tissue Eng A 20:1003–1011
Vaface T, Thomas D, Desai A et al (2016) Decellularization of human aortic and pulmonary valve conduits using low concentration sodium dodecyl sulphate. J Tissue Eng regen Med. https://doi.org/10.1002/term2391
Desai A, Vafaee T, Rooney P, Kearney JN, Berry HE, Ingham E, Fisher J, Jennings LM (2018) In vitro biomechanical and hydrodynamic characterisation of decellularised human pulmonary and aortic roots. J Mech Behav Biomed Mater 79:53–63
VeDepo M, Detamore M, Hopkins R, Converse G (2017) Recellularization of decellularized heart valves: progress toward the tissue engineered heart valve. J Tissue Eng 8:2041731417726327
Konuma T, Devaney E, Bove E et al (2009) Performance of Cryolife SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg 88:849–855
Helder MRK, Kouchoukos N, Zehr K et al (2016) Late durability of decellulrized allografts for aortic valve replacement: a word of caution. J Thorac Cardiovasc Surg 152:1197–1199
Da Costa FDA, Etnel JRG, Charitos EI et al (2018) Decellularized versus standard pulmonary allografts in the Ross Procedure: propensity-matched analysis. Ann Thorac Surg 105:1205–1213
Sarikouch S, Horke A, Tudorache I et al (2016) Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg 50:281–290
Yves d’Udekem, (2016) Decellularized homografts: in fashion or really superior?. Eur J Cardio-Thorac Surg 50(2):291–292
Brockbank K, Chen Z, Greene E, Campbell L (2015) Vitrification of heart valve tissues. Methods Mol Biol 1257:399–421
Huber A, Aberle T, Schleicher M et al (2013) Characterization of a simplified ice-free cryopreservation method for heart valves. Cell Tissue Bank 14:195–203
Boll BM, Vogt F, Boulesteix AL, Schmitz C (2015) Gender mismatch in allograft aortc valve surgery. Interact Cardiovasc Thorac Surg 21:329–335
Vogt F, Böll BM, Boulesteix A-L, Kilian E, Santarpino G, Reichart B, Schmitz C (2013) Homografts in aortic position: does blood group incompatibility have an impact on patient outcomes?†. Interact Cardiovasc Thorac Surg 16(5):619–624
Spacek M, Pavel M et al (2018) Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. Cell Tissue Bank 19:437–445
Heng WL, Seck T, Chiew PT et al (2013) Homograft Banking in Singapore: two years of cardiovascular tissue banking in sotheast asia. Cell Tissue Bank 14:187–194
Hoque R, Rashid Z, Sarkov SK (2007) Antibiotic sterilization of cadaveric homograft aortic valve for clinical use. Bangladesh Med Res Counc Bull 33(2):69–72
Verghese S, Padmaja P, Sindhu B et al(2004) Homograft valve bank:our experience in valve banking. Indian Heart J 56(4):299–306
Brockbank KM, Lightfoot FG, Song YC, Taylor MJ (2000) Interstitial ice formation in cryopreserved homografts: a possible cause of tissue deterioration and calcification in vivo. J Heart Valve Dis 9:200–206
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Parker, R. (2021). Banking of Heart Valves. In: Galea, G., Turner, M., Zahra, S. (eds) Essentials of Tissue and Cells Banking. Springer, Cham. https://doi.org/10.1007/978-3-030-71621-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-71621-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71620-2
Online ISBN: 978-3-030-71621-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)